IPO registrations (S-1, F-1) · Registrants
Fresh2 Group Ltd
- SEC CIK
- 1786511 · filings on EDGAR ↗
- Name on the registration
- AnPac Bio-Medical Science Co., Ltd.
- Former names
- AnPac Bio-Medical Science Co., Ltd. (2019–2023)
- Registration
- Form F-1, first filed 2019-10-31, last 2020-10-14; 2 initial registrations, 5 amendments
- Outcome
- Final prospectus filed 2020-01-31; declared effective 2020-01-28; withdrawal requested 2020-11-18
- Industry (SIC)
- Services-Medical Laboratories 8071
- Incorporated in
- D8
- Business address
- 880 3RD AVE, FLOOR 7, New York, NY 10022
- EDGAR entity type
- operating
- Insiders and CEO pay
- Fresh2 Group Ltd on the corporate pages
Offering terms
- Proposed price range
- $12.00–$14.00 per ADS (F-1/A filed 2019-12-11)
- Final price
- $12.00 per ADS, within the range (424B4 filed 2020-01-31, an initial public offering)
- Shares sold
- 1,333,360
- Gross proceeds
- $16,000,320 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ANPC
- Lead underwriters
- Univest Securities
- Syndicate
- WestPark Capital, Inc
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: AnPac Bio-Medical Science Co., Ltd. EXACT (CIK (EXACT))
- SEC filer: Fresh2 Group Ltd EXACT (CIK (EXACT))
Filings 12
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2019-10-31 | F-1 | F-1 (foreign registration) | AnPac Bio-Medical Science Co., Ltd. | 0001193125-19-280540 ↗ |
| 2019-11-15 | F-1/A | F-1/A (amendment) | AnPac Bio-Medical Science Co., Ltd. | 0001193125-19-293275 ↗ |
| 2019-12-05 | F-1/A | F-1/A (amendment) | AnPac Bio-Medical Science Co., Ltd. | 0001193125-19-306681 ↗ |
| 2019-12-11 | F-1/A | F-1/A (amendment) | AnPac Bio-Medical Science Co., Ltd. | 0001193125-19-311432 ↗ |
| 2020-01-06 | F-1/A | F-1/A (amendment) | AnPac Bio-Medical Science Co., Ltd. | 0001193125-20-001982 ↗ |
| 2020-01-28 | EFFECT | EFFECT (declared effective) | AnPac Bio-Medical Science Co., Ltd. | 9999999995-20-000173 ↗ |
| 2020-01-28 | EFFECT | EFFECT (declared effective) | AnPac Bio-Medical Science Co., Ltd. | 9999999995-20-000174 ↗ |
| 2020-01-31 | 424B4 | 424B4 (final prospectus) | AnPac Bio-Medical Science Co., Ltd. | 0001193125-20-020258 ↗ |
| 2020-09-30 | F-1 | F-1 (foreign registration) | AnPac Bio-Medical Science Co., Ltd. | 0001047469-20-005047 ↗ |
| 2020-10-14 | F-1/A | F-1/A (amendment) | AnPac Bio-Medical Science Co., Ltd. | 0001047469-20-005190 ↗ |
| 2020-11-18 | RW | RW (withdrawal request) | AnPac Bio-Medical Science Co., Ltd. | 0001104659-20-126856 ↗ |
| 2021-06-07 | EFFECT | EFFECT (declared effective) | AnPac Bio-Medical Science Co., Ltd. | 9999999995-21-002245 ↗ |
Prospectus pages read 3
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-12-11 | F-1/A | registration statement | $12.00–$14.00 | 1,666,700 | - | Nasdaq ANPC | 2 | primary document; range, shares headline, cover names 2 | document ↗ | |
| 2020-01-06 | F-1/A | registration statement | - | - | 0 | primary document; no terms found | document ↗ | |||
| 2020-01-31 | 424B4 | final prospectus | $12.00 | 1,333,360 | $16,000,320 | Nasdaq ANPC | 2 | primary document; price line, shares headline, proceeds table, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Xu Haohan | Director,Officer,TenPercentOwner | Chief Executive Officer | 2 | 2024 | |
| Liang Zhijun | Director | 1 | 2024 | ||
| Li Xiaoyu | Director,Officer | Chief Financial Officer | 1 | 2024 | |
| Pu Tianruo | Director | 1 | 2024 | ||
| Tian Honggang | Director | 1 | 2024 | ||
| Zhao Zhigang | Director | 1 | 2024 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2022-06-13 | AnPac Bio-Medical Science Co., Ltd. | Biotechnology | $1,500,000 | $1,500,000 | 1 | 1 |
| 2022-06-13 | AnPac Bio-Medical Science Co., Ltd. | Biotechnology | $1,500,000 | $1,500,000 | 1 | 1 |
| 2022-05-27 | AnPac Bio-Medical Science Co., Ltd. | Biotechnology | $1,400,000 | $1,400,000 | 1 | 1 |
| 2020-08-24 | AnPac Bio-Medical Science Co., Ltd. | Biotechnology | $265,000 | $265,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | AnPac Bio-Medical Science Co., Ltd. | Form D private offerings | CIK (EXACT) | |
| SEC filer | Fresh2 Group Ltd | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Medical Laboratories, NY first:
- IMPATH INC NY
- DYNACARE INC A6
- INSIGHT HEALTH SERVICES CORP CA
- QUEST DIAGNOSTICS INC NJ
- AMERIPATH INC FL
- PRECISION THERAPEUTICS INC PA
- CLARIENT, INC CA
- BIOCEPT INC CA
- SPECIALTY LABORATORIES INC CA
- EXACT SCIENCES CORP WI
In other datasets, the same topic (Health) in NY:
- Nonprofit: AABR FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Services-Medical Laboratories · Health